While nutlin-3 initially was thought to exert its anti-cancer activity specifically through inhibition of the p53-MDM2 interaction, recent studies have demonstrated dual-targeting and p53 independent effects of nutlin-3 [11-13]. This evidence concerns the gene TP53 and cancer.